// App-Quantinova.ai

324 : Modeling sequential systemic therapy for unresectable hepatocellular carcinoma in the era of immunotherapy: What comes next?

Researchers

Presenter

  • Ciro Celsa

Principal Investigators

  • Giuseppe Cabibbo

  • Marco Enea

  • Salvatore Battaglia

  • Giacomo Emanuele Maria Rizzo

  • Calogero Camm

Medical Centers

  • University of Palermo, Palermo, Italy

  • Universita degli Studi di Palermo, Palermo, Italy

  • Section of Gastroeneterology and Hepatology, University of Palermo, Palermo, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

  • Atezolizumab

  • Cabozantinib

  • Bevacizumab

  • Regorafenib

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved